Skip to main content
. 2021 Mar 25;31(2):114–125. doi: 10.1089/nat.2020.0879

FIG. 1.

FIG. 1.

Annual change in number of consultations on oligonucleotide therapeutics. This graph shows a recent increasing trend in both Japan (PMDA) and the EU (EMA). EMA, European Medicines Agency; PMDA, Pharmaceuticals and Medical Devices Agency.